555 related articles for article (PubMed ID: 29051992)
1. Adverse outcome pathways: opportunities, limitations and open questions.
Leist M; Ghallab A; Graepel R; Marchan R; Hassan R; Bennekou SH; Limonciel A; Vinken M; Schildknecht S; Waldmann T; Danen E; van Ravenzwaay B; Kamp H; Gardner I; Godoy P; Bois FY; Braeuning A; Reif R; Oesch F; Drasdo D; Höhme S; Schwarz M; Hartung T; Braunbeck T; Beltman J; Vrieling H; Sanz F; Forsby A; Gadaleta D; Fisher C; Kelm J; Fluri D; Ecker G; Zdrazil B; Terron A; Jennings P; van der Burg B; Dooley S; Meijer AH; Willighagen E; Martens M; Evelo C; Mombelli E; Taboureau O; Mantovani A; Hardy B; Koch B; Escher S; van Thriel C; Cadenas C; Kroese D; van de Water B; Hengstler JG
Arch Toxicol; 2017 Nov; 91(11):3477-3505. PubMed ID: 29051992
[TBL] [Abstract][Full Text] [Related]
2. Development and application of the adverse outcome pathway framework for understanding and predicting chronic toxicity: I. Challenges and research needs in ecotoxicology.
Groh KJ; Carvalho RN; Chipman JK; Denslow ND; Halder M; Murphy CA; Roelofs D; Rolaki A; Schirmer K; Watanabe KH
Chemosphere; 2015 Feb; 120():764-77. PubMed ID: 25439131
[TBL] [Abstract][Full Text] [Related]
3. Building and Applying Quantitative Adverse Outcome Pathway Models for Chemical Hazard and Risk Assessment.
Perkins EJ; Ashauer R; Burgoon L; Conolly R; Landesmann B; Mackay C; Murphy CA; Pollesch N; Wheeler JR; Zupanic A; Scholz S
Environ Toxicol Chem; 2019 Sep; 38(9):1850-1865. PubMed ID: 31127958
[TBL] [Abstract][Full Text] [Related]
4. Editorial trend: adverse outcome pathway (AOP) and computational strategy - towards new perspectives in ecotoxicology.
Baudiffier D; Audouze K; Armant O; Frelon S; Charles S; Beaudouin R; Cosio C; Payrastre L; Siaussat D; Burgeot T; Mauffret A; Degli Esposti D; Mougin C; Delaunay D; Coumoul X
Environ Sci Pollut Res Int; 2024 Jan; 31(5):6587-6596. PubMed ID: 37966636
[TBL] [Abstract][Full Text] [Related]
5. Linking Mitochondrial Dysfunction to Organismal and Population Health in the Context of Environmental Pollutants: Progress and Considerations for Mitochondrial Adverse Outcome Pathways.
Dreier DA; Mello DF; Meyer JN; Martyniuk CJ
Environ Toxicol Chem; 2019 Aug; 38(8):1625-1634. PubMed ID: 31034624
[TBL] [Abstract][Full Text] [Related]
6. Quantification of an Adverse Outcome Pathway Network by Bayesian Regression and Bayesian Network Modeling.
Moe SJ; Wolf R; Xie L; Landis WG; Kotamäki N; Tollefsen KE
Integr Environ Assess Manag; 2021 Jan; 17(1):147-164. PubMed ID: 32965776
[TBL] [Abstract][Full Text] [Related]
7. Advancing the adverse outcome pathway framework-An international horizon scanning approach.
LaLone CA; Ankley GT; Belanger SE; Embry MR; Hodges G; Knapen D; Munn S; Perkins EJ; Rudd MA; Villeneuve DL; Whelan M; Willett C; Zhang X; Hecker M
Environ Toxicol Chem; 2017 Jun; 36(6):1411-1421. PubMed ID: 28543973
[TBL] [Abstract][Full Text] [Related]
8. Semantic characterization of adverse outcome pathways.
Wang RL
Aquat Toxicol; 2020 May; 222():105478. PubMed ID: 32278258
[TBL] [Abstract][Full Text] [Related]
9. Example of Adverse Outcome Pathway Concept Enabling Genome-to-Phenome Discovery in Toxicology.
Gust KA; Ji Q; Luo X
Integr Comp Biol; 2020 Aug; 60(2):375-384. PubMed ID: 32516358
[TBL] [Abstract][Full Text] [Related]
10. When Are Adverse Outcome Pathways and Associated Assays "Fit for Purpose" for Regulatory Decision-Making and Management of Chemicals?
Coady K; Browne P; Embry M; Hill T; Leinala E; Steeger T; Maślankiewicz L; Hutchinson T
Integr Environ Assess Manag; 2019 Jul; 15(4):633-647. PubMed ID: 30908812
[TBL] [Abstract][Full Text] [Related]
11. A case example of a radiation-relevant adverse outcome pathway to lung cancer.
Chauhan V; Sherman S; Said Z; Yauk CL; Stainforth R
Int J Radiat Biol; 2021; 97(1):68-84. PubMed ID: 31846388
[TBL] [Abstract][Full Text] [Related]
12. Expert consultation is vital for adverse outcome pathway development: a case example of cardiovascular effects of ionizing radiation.
Chauhan V; Hamada N; Monceau V; Ebrahimian T; Adam N; Wilkins RC; Sebastian S; Patel ZS; Huff JL; Simonetto C; Iwasaki T; Kaiser JC; Salomaa S; Moertl S; Azimzadeh O
Int J Radiat Biol; 2021; 97(11):1516-1525. PubMed ID: 34402738
[TBL] [Abstract][Full Text] [Related]
13. AOP-helpFinder 2.0: Integration of an event-event searches module.
Jaylet T; Coustillet T; Jornod F; Margaritte-Jeannin P; Audouze K
Environ Int; 2023 Jul; 177():108017. PubMed ID: 37295163
[TBL] [Abstract][Full Text] [Related]
14. Development of a putative adverse outcome pathway network for male rat reproductive tract abnormalities with specific considerations for the androgen sensitive window of development.
Palermo CM; Foreman JE; Wikoff DS; Lea I
Curr Res Toxicol; 2021; 2():254-271. PubMed ID: 34401750
[TBL] [Abstract][Full Text] [Related]
15. Adverse outcome pathways potentially related to hazard identification of microplastics based on toxicity mechanisms.
Jeong J; Choi J
Chemosphere; 2019 Sep; 231():249-255. PubMed ID: 31129406
[TBL] [Abstract][Full Text] [Related]
16. Adverse outcome pathway: a path toward better data consolidation and global co-ordination of radiation research.
Chauhan V; Beaton D; Hamada N; Wilkins R; Burtt J; Leblanc J; Cool D; Garnier-Laplace J; Laurier D; Le Y; Yamada Y; Tollefsen KE
Int J Radiat Biol; 2022; 98(12):1694-1703. PubMed ID: 34919011
[TBL] [Abstract][Full Text] [Related]
17. The adverse outcome pathway concept: a pragmatic tool in toxicology.
Vinken M
Toxicology; 2013 Oct; 312():158-65. PubMed ID: 23978457
[TBL] [Abstract][Full Text] [Related]
18. Adverse outcome pathway from activation of the AhR to breast cancer-related death.
Benoit L; Jornod F; Zgheib E; Tomkiewicz C; Koual M; Coustillet T; Barouki R; Audouze K; Vinken M; Coumoul X
Environ Int; 2022 Jul; 165():107323. PubMed ID: 35660951
[TBL] [Abstract][Full Text] [Related]
19. Linking nanomaterial-induced mitochondrial dysfunction to existing adverse outcome pathways for chemicals.
Murugadoss S; Vinković Vrček I; Schaffert A; Paparella M; Pem B; Sosnowska A; Stępnik M; Martens M; Willighagen EL; Puzyn T; Roxana Cimpan M; Lemaire F; Mertens B; Dusinska M; Fessard V; Hoet PH
ALTEX; 2024 Jan; 41(1):76-90. PubMed ID: 37606097
[TBL] [Abstract][Full Text] [Related]
20. Application of the adverse outcome pathway framework to genotoxic modes of action.
Sasaki JC; Allemang A; Bryce SM; Custer L; Dearfield KL; Dietz Y; Elhajouji A; Escobar PA; Fornace AJ; Froetschl R; Galloway S; Hemmann U; Hendriks G; Li HH; Luijten M; Ouedraogo G; Peel L; Pfuhler S; Roberts DJ; Thybaud V; van Benthem J; Yauk CL; Schuler M
Environ Mol Mutagen; 2020 Jan; 61(1):114-134. PubMed ID: 31603995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
